In today’s session Usa Compression Partners LP (USAC) recorded an unusually high (395) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the March, 2017 put, expecting serious USAC decrease. With 395 contracts traded and 374 open interest for the Mar, 17 contract, it seems this is a quite bearish bet. The option with symbol: USAC170317P00017500 closed last at: $1.55 or 11.4% down. The stock decreased 1.14% or $0.21 on October 4, hitting $18.19. About 54,794 shares traded hands. Usa Compression Partners LP (NYSE:USAC) has risen 102.32% since March 1, 2016 and is uptrending. It has outperformed by 93.08% the S&P500.
Analysts await Usa Compression Partners LP (NYSE:USAC) to report earnings on November, 3. They expect $0.07 EPS, down 66.67% or $0.14 from last year’s $0.21 per share. USAC’s profit will be $4.69M for 64.96 P/E if the $0.07 EPS becomes a reality. After $0.05 actual EPS reported by Usa Compression Partners LP for the previous quarter, Wall Street now forecasts 40.00% EPS growth.
Usa Compression Partners LP (NYSE:USAC) Ratings Coverage
Out of 4 analysts covering USA Compression Partners LP (NYSE:USAC), 2 rate it a “Buy”, 2 “Sell”, while 0 “Hold”. This means 50% are positive. USA Compression Partners LP has been the topic of 13 analyst reports since July 28, 2015 according to StockzIntelligence Inc. As per Friday, May 6, the company rating was maintained by RBC Capital Markets. The firm has “Neutral” rating given on Thursday, May 12 by Goldman Sachs. The firm has “Underweight” rating by Barclays Capital given on Monday, January 11. The stock of Usa Compression Partners LP (NYSE:USAC) has “Neutral” rating given on Tuesday, July 28 by JP Morgan. The firm earned “Outperform” rating on Friday, November 6 by RBC Capital Markets. FBR Capital initiated it with “Outperform” rating and $21 target price in Friday, September 9 report. The stock of Usa Compression Partners LP (NYSE:USAC) has “Sell” rating given on Tuesday, June 21 by Goldman Sachs.
Insitutional Activity: The institutional sentiment increased to 1.38 in Q2 2016. Its up 0.38, from 1 in 2016Q1. The ratio improved, as 9 funds sold all Usa Compression Partners LP shares owned while 12 reduced positions. 12 funds bought stakes while 17 increased positions. They now own 55.05 million shares or 0.52% less from 55.33 million shares in 2016Q1.
First Manhattan holds 2,680 shares or 0% of its portfolio. Guggenheim Cap Ltd Llc last reported 58,504 shares in the company. Citigroup, a New York-based fund reported 634,851 shares. First Fincl Corp In last reported 470 shares in the company. Jpmorgan Chase has 40,043 shares for 0% of their US portfolio. Tower Rech Cap Llc (Trc) last reported 0% of its portfolio in the stock. Moreover, Manufacturers Life Insurance The has 0% invested in Usa Compression Partners LP (NYSE:USAC) for 1,203 shares. Hodges reported 10,000 shares or 0.01% of all its holdings. Pnc Financial Services Grp owns 134,390 shares or 0% of their US portfolio. Cohen And Steers holds 0.01% or 167,009 shares in its portfolio. Barclays Public Ltd Co holds 0% of its portfolio in Usa Compression Partners LP (NYSE:USAC) for 76,951 shares. Gsa Cap Prns Llp last reported 22,745 shares in the company. Spirit Of America Mgmt Corp Ny has 1.91% invested in the company for 890,566 shares. Davenport And Co Ltd Com last reported 16,300 shares in the company. Neuberger Berman Group Ltd Liability last reported 269,400 shares in the company.
USA Compression Partners, LP is an independent well-known provider of compression services in the United States. The company has a market cap of $1.22 billion. The Firm provides compression services to its clients primarily in connection with infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and managing crude oil production through artificial lift processes. It currently has negative earnings. The Company’s segment is the compression services business.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.